About Us
RadPharm is a leading imaging core lab, managing the complete imaging segment of clinical trials for the global pharmaceutical, biotechnology and medical device industries. With greater than 16 years experience supporting over 350 clinical trials, across 60 countries and 6,000 unique sites, RadPharm’s vast expertise spans early stage through phase IV studies and all major therapeutic areas. In addition to having a specialty in oncology trials, we also possess deep experience with cardiovascular, musculoskeletal, CNS, diagnostic contrast imaging agents and medical device studies.
RadPharm employs board-certified, sub-specialty trained radiologists, nuclear physicians and medical oncologists, uniquely positioning us to focus on the Medicine Behind the ImageTM. Our experienced medical staff interprets data from all major modalities, including, but not limited to, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), X-ray, Single Photon Emission Computed Tomography (SPECT), Ultrasound, Positron Emission Tomography (PET) and PET/CT.
We provide centralized, independent, unbiased interpretation of medical images for clinical trials, integrated with a proven planning, tracking and implementation process specifically designed to exceed your expectations and timelines. RadPharm speeds delivery of your product to market by supporting your trial program with medical expertise, regulatory know-how and advanced, validated technologies.
Learn how RadPharm can optimize your drug development program - Contact us today at info@radpharm.com. |
